Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Telomeric Repeat-binding Factor 1 (TERF1), also known as TRF1, is a crucial component of the shelterin complex, a specialized multiprotein complex that protects the ends of chromosomes (telomeres) in mammalian cells. TERF1 directly binds to the TTAGGG telomeric DNA repeats. Its primary biological functions include regulating telomere length by inhibiting telomerase, protecting chromosome ends from being recognized as DNA damage, facilitating efficient replication through telomeric regions, and organizing telomeric chromatin structure. Deregulation, particularly overexpression, of TERF1 has been implicated in the development and progression of various cancers, where it contributes to sustained proliferation and survival of malignant cells, making it an attractive therapeutic target for cancer treatment.
Drugs targeting TERF1 typically aim to disrupt its binding to telomeric DNA, interfere with its protein-protein interactions within the shelterin complex, or promote its degradation. This leads to telomere deprotection, increased telomere shortening, activation of DNA damage responses at telomeres, and induction of cellular senescence or apoptosis in cancer cells, thereby inhibiting tumor growth.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomeric repeat-binding factor 1 (TERF1).